Global Gastrointestinal Diseases Drug Development Market will exhibit a CAGR of around 6.90% for the forecast period of 2021-2028. From the name itself, it is clear that gastrointestinal diseases are the diseases related to the gastrointestinal tract. A few examples of gastrointestinal diseases are constipation, inflammatory bowel diseases, irritable bowel syndrome, colitis, and so on. Get Full Access of Report @ https://www.databridgemarketresearch.com/reports/global-gastrointestinal-diseases-drug-development-market
Global gastrointestinal bleeding treatment devices market size is expected to reach $1.2 Bn by 2028 at a rate of 7.6% segmented as by product, endoscopic thermal devices, other products
The global branded generics market size will grow from $304.16 billion in 2022 to $329.98 billion in 2023 at a compound annual growth rate (CAGR) of 8.5%.
The Business Research Company offers gastrointestinal bleeding treatment devices market research report 2023 with industry size, share, segments and market growth
The gastrointestinal drugs market size is expected to reach $65 billion by 2022, significantly growing at a CAGR of around 4.5% during the forecast period. The growth in the gastrointestinal drugs market can be attributed to the expected increase in prevalence of obesity and digestive diseases globally. Read more at https://bit.ly/2StzjHk
The global gastrointestinal bleeding treatment devices market size grew from $0.78 billion in 2022 to $0.83 billion in 2023 at a compound annual growth rate (CAGR) of 6.1%.
Endoscopic appliers are pin like structures, which have a holding type structure on its edges, and have an ability to pierce the human body muscle. It is used to check up the interior body part of the human, to examine digestive system or any interior problem.
The global gastrointestinal drugs market was valued at above $54 billion in 2017. North America was the largest region in the gastrointestinal drugs market in 2017, accounting for above 30% market share. Read Report https://www.thebusinessresearchcompany.com/report/gastrointestinal-drugs-global-market-report-2018
Europe Dog Dewormers Market is referred to as deworming. "Some cause muscle spasms, paralysing the worm and allowing the gastrointestinal tract to get rid of it. Regular faecal examinations, which aid in the diagnosis of various types of intestinal worms, complement deworming. The frequency with which your veterinarian requests a faecal sample will be determined by several factors, including the prevalence of local disease and your dog's lifestyle, but you should generally expect to send a sample once or twice a year.
Marketreportsonrussia.com presents a report on “Russia Gastrointestinal (GI) Stenting Procedures Outlook to 2020”The objective is to provide information that represents the most up-to-date data of the industry possible.
This study forecasts that the global branded generics market revenue is likely to grow more than double by 2030. The current scenario is such that “Generic” names are more popular than the branded ones. For instance – “Amoxicillin” is a well-known drug to treat bacterial infections. However, it’s not “branded” by any means. The “branded” name is “Trimox”.
Global Fluoroscopy Systems Market, By Product Type (Remote Controlled Systems, Patient-Side Controlled Systems, C-Arms), Application (Orthopedic, Cardiovascular, Pain Management and Trauma, Neurology, Gastrointestinal, Urology, General Surgery, Others), End User (Hospitals, Diagnostic Centers, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Global digestive and intestinal remedies market size is expected to reach $27.36 Bn by 2028 at a rate of 6.1%, segmented as by type, digestive medicines, remedies against gastrointestinal complaints, natural and synthetic agents
Global otc drug and dietary supplement market size is expected to reach $438.93 Bn by 2028 at a rate of 7.2%, segmented as by category, vitamin and dietary supplements, cough and cold products, analgesics, gastrointestinal products, sleep aids
The global capsule endoscopy market size reached US$ 485.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 938.4 Million by 2032, exhibiting a growth rate (CAGR) of 7.4% during 2024-2032.
The global human microbiome market size reached US$ 817.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,586.3 Million by 2032, exhibiting a growth rate (CAGR) of 17.3% during 2024-2032.
Global pharmaceutical drugs market size is expected at 1,848.49 Bn by 2027 at a growth rate of 11.4% and industry demand by The Business Research Company.
The global transdermal skin patches market is primarily driven by the increasing demand for non-invasive medication over oral and ingesting medicines that causes gastrointestinal toxicity, nausea, and vomiting. The associated benefits of transdermal drug delivery, such as reducing inconvenience caused by intravenous or parenteral therapies, are also propelling their demand worldwide. Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/transdermal-skin-patches-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
In the year 2023, the carcinoembryonic antigen market was estimated to be worth 1.11 billion USD. Forecasts indicate that the carcinoembryonic antigen market will expand from $1.36 billion in 2024 to $3.99 billion in 2031, a CAGR (compound annual growth rate) of 17.2% from 2024 to 2031.
Global viral gastroenteritis market size is expected to reach $8.1 Bn by 2028 at a rate of 4.9%, segmented as by drugs, antibiotics, antacids, laxatives, antimotility agents, others drugs
The rising prevalence of various chronic medical conditions, including cancer, diabetes, cardiovascular diseases (CVDs), gastrointestinal disorders, etc., particularly among the geriatric population, is primarily driving the X-ray machine manufacturing market. Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/x-ray-machine-manufacturing-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
Global phage therapy market is expected to foresee a compound annual growth rate of 8.1% from 2021 to 2028. The major factors driving the growth of the phage therapy market are antibiotics resistance, the increased prevalence of food-borne diseases, use of phage therapy in the food & beverage industry, application of bacteriophage specific to target bacteria, extensive research & development, and increasing antimicrobial resistance. Nowadays antibiotics resistance has become one of the biggest threats to global health as it can affect people of any age group.
Global neuroendocrine tumor treatment market size is expected at $2.88 Bn by 2027 at a growth rate of 10.5% and growth analysis by The Business Research Company.
Global contrast media market size is expected to reach $5.65 Bn by 2028 at a rate of 4.6%, segmented as by type, barium-based contrast media, iodinated contrast media, gadolinium-based contrast media, microbubble contrast media
The rising prevalence of various chronic diseases, particularly end stage kidney disease (ESKD), across the globe is a significant factor driving the growth of the market Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/hyperphosphatemia-drugs-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
The global rigid endoscope market size is expected to grow from $4.22 billion in 2022 to $4.60 billion in 2023 at a compound annual growth rate (CAGR) of 8.9%.
Global neuroendocrine tumor treatment market size is expected at $2.88 Bn by 2027 at a growth rate of 10.5% and growth analysis by The Business Research Company.
Ligation devices market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 1.38 billion by 2027 growing at a CAGR of 6.38% in the above-mentioned forecast period. Increasing number of gastrointestinal and gynaecological procedures is expected to create new opportunity for the market.
The global endoscopy devices and equipment market size will grow from $7.9 billion in 2022 to $8.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.6%.
Global rigid endoscope market size is expected to reach $6.76 Bn by 2028 at a rate of 7.8%, segmented as by types, laparoscope, arthroscope, gynecological endoscope, ent endoscopy, urology endoscopy, neurology endoscopy, other types
According to the latest research report by IMARC Group, The global eubiotics market is expected to exhibit a growth rate (CAGR) of 7.1% during 2023-2028. More Info:- https://www.imarcgroup.com/eubiotics-market
The global surgical imaging market is estimated to garner a revenue of USD 4.0 Billion by the end of 2033 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2033.
The market is primarily driven by the rising incidence of road accidents, trauma, and several bleeding disorders. In addition, the increasing product adoption to prevent blood loss in women suffering from menorrhagia and during cardiovascular and neuro surgeries represents another major growth-inducing factor Get a PDF Sample for more detailed market insights: Visit the following link: https://www.imarcgroup.com/antifibrinolytic-drugs-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
Anastomosis device market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 3581.30 million by 2027 growing at a CAGR of 6.9% in the above-mentioned forecast period. Growth in healthcare industry and increasing number of gastrointestinal & urological surgery procedures are further creating new opportunities for the market in the forecast period of 2020 to 2027.
Global hospital emergency department market size is expected at $165.95 Bn by 2027 at a growth rate of 5.2% and overview by The Business Research Company.
Global gastric cancer diagnostic procedure market size is expected to reach $1.88 Bn by 2028 at a rate of 7.1%, segmented as by procedure type, endoscopic procedure, biopsy, tissue tests, lab tests, in-vitro diagnostic tests, imaging tests
Anastomosis device market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 3581.30 million by 2027 growing at a CAGR of 6.9% in the above-mentioned forecast period. Growth in healthcare industry and increasing number of gastrointestinal & urological surgery procedures are further creating new opportunities for the market in the forecast period of 2020 to 2027.
Global botanical supplements market size is expected to reach $88.2 Bn by 2028 at a rate of 9.2%, segmented as by source, herbs, leaves, spices, flowers, other sources
The global pharmaceutical drugs market was valued around $935 billion in 2017. North America was the largest region in the pharmaceutical drugs market in 2017, accounting for around 37% of the total market. The USA was the largest country in the market accounting for around 25% of the total market.
The dermatology drugs market size is expected to reach $40 billion by 2022, significantly growing at a CAGR of around 5% during the forecast period. The growth in the Dermatology drugs market is due to increase in the number of indications treated by topical drugs coupled with increase in acne and rosacea patients will drive the market for dermatology drugs. Read more at https://bit.ly/2BnUmRJ
According to the latest research report by IMARC Group, The global oncology injectables market is expected to exhibit a growth rate (CAGR) of 10.8% during 2023-2028. More Info:- https://www.imarcgroup.com/oncology-injectables-market
The cardiovascular drugs market size is expected to reach $140 billion by 2022, significantly growing at a CAGR of around 2% during the forecast period. The growth in the Cardiovascular drugs market is due to increase in aging population, increase in the prevalence of cardiovascular diseases and availability of more generic drugs that reduce the cost of treatment. Read Report https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report
Global Oncology Nutrition Market, By Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)- Industry Trends and Forecast to 2025